Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has become a substantial holder in Australian Clinical Labs Limited, with a 5.06% voting power through 10,206,184 fully paid ordinary shares. This move, effective as of May 15, 2024, positions Mitsubishi UFJ Financial Group as a significant investor with relevant interests in securities held by Morgan Stanley and First Sentier Investors Holdings Pty Limited.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
